Drug Testing Locations - Scott Township, PA

Drug Testing in Scott Township, PA

Scott Township, Pennsylvania Statistics

Scott Township, Lackawanna County, reported a 15% increase in opioid-related deaths from 2020 to 2021.

In 2021, over 200 drug-related arrests were made in Scott Township, Lackawanna County.

The rate of emergency room visits due to drug overdose in Scott Township, Lackawanna County increased by 22% over the last year.

A study showed that 7% of high school students in Scott Township, Lackawanna County have tried prescription drugs for non-medical use.

Scott Township, Lackawanna County held 10 drug take-back events in 2022, collecting over 500 lbs of unused medications.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Scott Township, PA & Drug Testing Policies

Employers in Scott Township, PA, have developed comprehensive drug testing policies to ensure workplace safety. Many local companies adhere to federal guidelines provided by the U.S. Department of Labor regarding drug-free workplaces, which include pre-employment testing and random testing procedures.

Some employers partner with local health services to provide employee assistance programs. These programs often include counseling and rehab referrals for workers struggling with substance abuse. Drug education is a part of the workplace culture in many establishments in Scott Township, fostering a supportive environment for recovery.

Scott Township businesses often implement zero-tolerance policies and engage in community efforts to foster a wider culture against drug use. They collaborate with local law enforcement for educational workshops focused on prevention. Employers strive to maintain productivity and safety while supporting employees.

Government Efforts with Drug Problems in Scott Township, PA

In Scott Township, PA, local government efforts focus heavily on prevention and education to combat drug abuse. Partnerships with organizations such as the Pennsylvania Department of Drug and Alcohol Programs aim to provide resources and awareness campaigns. Community-based initiatives are also supported to engage locals in the fight against drug abuse.

Moreover, initiatives like the Scott Township Police Department's outreach programs, which provide resources for treatment and recovery, are part of the broader strategy in Lackawanna County. State programs help facilitate funding and training efforts. The Pennsylvania Department of Health also provides guidelines and support for local health departments dealing with addiction-related issues.

Local Drug Busts & News in Scott Township, PA

Local drug busts in Scott Township, PA, have been increasing with increased law enforcement efforts in Lackawanna County. A notable operation in 2023 led to significant arrests and the seizure of large quantities of illegal substances, thus impacting community safety positively.

Regular drug-related events, such as the drug take-back days sponsored by local police and the community health department, aim to reduce the availability of expired or unused medications. These events increase community engagement and awareness of drug abuse issues.

Scott Township has hosted several public forums to address the drug crisis. These events bring together law enforcement officers, community leaders, and health professionals to discuss strategies and initiatives designed to combat substance abuse in the township.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Scott Township, PA. Trusted by employers nationwide for accurate results and exceptional service.

Pennsylvania DOT/Non DOT Physicals

Pennsylvania Vision Tests

Pennsylvania Audiograms

Pennsylvania Respirator Fit Tests

Pennsylvania Lift Tests

Pennsylvania Background Checks

Clinical Testing Services

TB Testing in PA

Diabetes Testing in PA

Infectious Disease Testing in PA

Sickle Cell Anemia Testing in PA

Women/Men's Health Testing in PA

Resources & Citations

Pennsylvania Department of Drug and Alcohol Programs

Pennsylvania Department of Health

Center of Excellence for o-drug Use Disorder

Scranton Counseling Center

Clearbrook Treatment Centers

Lackawanna/Susquehanna Office of Drug & Alcohol Programs

Geisinger Community Health

Mental Health Association in Pennsylvania

Drug Testing Near Scott Township, PA

Rennerdale, PA

Walkers Mill, PA

Crafton, PA

Thornburg, PA

Pennsbury Village, PA

Bridgeville, PA

Rosslyn Farms, PA

Dormont, PA

Green Tree, PA

Presto, PA

Bower Hill, PA

Heidelberg, PA

Frequently Asked Questions

Customer Reviews